Royal Bank of Canada
KRTX

Royal Bank of Canada’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Royal Bank of Canada’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-29,693
Closed -$9.4M – 7816
2023
Q4 		$9.4M Buy
29,693
+6,830
+30% +$1.33M ﹤0.01% 1763
2023
Q3 		$3.87M Buy
22,863
+11,862
+108% +$2.23M ﹤0.01% 2298
2023
Q2 		$2.39M Sell
11,001
-1,142
-9% -$245K ﹤0.01% 2699
2023
Q1 		$2.21M Buy
12,143
+486
+4% +$92.9K ﹤0.01% 2729
2022
Q4 		$2.29M Buy
11,657
+6,548
+128% +$1.4M ﹤0.01% 2789
2022
Q3 		$1.15M Buy
5,109
+4,892
+2,254% +$990K ﹤0.01% 3332
2022
Q2 		$28K Sell
217
-1,190
-85% -$137K ﹤0.01% 5966
2022
Q1 		$178K Sell
1,407
-3,666
-72% -$413K ﹤0.01% 5190
2021
Q4 		$665K Buy
5,073
+2,997
+144% +$387K ﹤0.01% 4228
2021
Q3 		$254K Sell
2,076
-1,748
-46% -$202K ﹤0.01% 4953
2021
Q2 		$436K Buy
3,824
+2,801
+274% +$327K ﹤0.01% 4407
2021
Q1 		$123K Buy
1,023
+853
+502% +$96.6K ﹤0.01% 5321
2020
Q4 		$17K Buy
+170
New +$15.8K ﹤0.01% 6147
2020
Q2 		– Sell
-48
Closed -$3K – 6998
2020
Q1 		$3K Buy
+48
New +$4.11K ﹤0.01% 6228

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Royal Bank of Canada's KRTX Position: Q1 2024 in Review

Royal Bank of Canada sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 29,693 shares — an estimated $9.4M sold.

Royal Bank of Canada first reported a position in KRTX in Q1 2020 and held it in 14 quarters. The position peaked at $9.4M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Royal Bank of Canada reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 29,693 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $9.4M.
  • Royal Bank of Canada first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
  • Royal Bank of Canada's Karuna Therapeutics, Inc. Common Stock position peaked at $9.4M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Royal Bank of Canada's 13F filing for Q1 2024, filed 15 May 2024.